Beyond Cancer: CAR T Therapy Targets Autoimmunity, Infection, and More

Published on Spencer Knight via LinkedIn

CAR T-cell therapy has revolutionized oncology, but its next frontier is outside of cancer altogether. Spencer Knight shares a visual overview of current and emerging CAR T targets in non-oncological areas like autoimmune disease, infection, fibrosis, hemophilia, and even aging.

Targets like CD19-BCMA are already showing promise for lupus, while other constructs aim to treat chronic infections and fibrotic tissue. This next wave of CARs could redefine the future of immune engineering across medicine, not just oncology.

Read the full post on LinkedIn:

👉 Spencer Knight: CAR T Therapy in Non-Oncology

Images used are for illustrative purposes only and do not depict actual persons, products, or facilities. For full details, please refer to the original article via the provided link.